Drug Controller General permits clinical trial of convalescent plasma in COVID-19 patients - (The Economic Times via NewsPoints Desk)

  • India's central drug regulator has approved a proposal by the Indian Council of Medical Research (ICMR) for the clinical trial of convalescent plasma in COVID-19 patients, as per the protocol developed by ICMR, The Economic Times reported on Sunday.

  • The Drug Controller General of India said ICMR has submitted a list of institutes that are interested in the trial to the Central Drugs Standard Control Organisation.

  • "It is to inform that in light of public interest the proposal of ICMR for conducting the said trial has been reviewed through the Subject Expert Committee in its meeting held on April 13 under accelerated approval process in light of the current prevailing situation of COVID-19 and based on the recommendation of the committee," the regulator said.

To read more NewsPoints articles, click here.